Usha Sharma – Mumbai
With an aim to promote Indian pharma industry globally, Government of Gujarat will sign a memorandum of understanding (MOU) with UK MHRA, at the Vibrant Gujarat 2013 Summit, to be held from January 11-13, 2013. The state government is focussing on knowledge and networking rather than encouraging investment.
Dr HG Koshia, Commissioner, Food & Drugs Control Administration, Gujarat said, “In Gujarat we have enough investments and the Government is therefore looking beyond the investment peripheral. The government is encouraging knowledge and networking in the pharma sphere.”
In a collaboration with UK MHRA, the Food & Drugs Control Administration (FDCA), Government of Gujarat will organise a seminar where discussions will be held on various regulatory requirements of EU and UK MHRA. During the seminar it will be addressing the issues related to the regulatory inspections and GMP requirements. The seminar is being sponsored by UK Trade & Investment (UKTI) which is a trade promotion body of the UK MHRA. Around 100-120 participants are going to take part in the seminar.
Koshia continued, “To give an updated knowledge to the pharma industry in Gujarat, we are organising technical seminar in collaboration with UK MHRA. Certainly, this will help pharma companies to know about updated regulatory requirements. We will be showcasing the e-governance developed by the FDCA and will be discussing this technologies in detail.”
Speaking about the MoU, Koshia added, “This year in Gujarat, many global giants like Teva and Abbott have set up their ventures. A few more are in the pipeline as well. Considering this fact, we are expecting to close the MoU in similar lines of last Vibrant Gujarat.”
